Buradasınız

Anasayfa » Content

Renal Transplant Hastalarında Arteriyovenöz Fistüllerin Kapatılması

Closure of Arteriovenous Fistulas After Renal Transplantation

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
After successful renal transplantation, the subject of protection of arteriovenous fistula is under debate. Arteriovenous fistulas lead to left ventricular volume overload and eccentric left ventricular hypertrophy. After renal transplantation, if arteriovenous fistulas are preserved, presence of left ventricular hypertrophy increases. However, the return of left ventricle to normal geometry is not observed and blood pressure may increase with the closure of arteriovenous fistulas. In addition, finding of new vascular access for arteriovenous fistula might be diffucult if hemodialysis is needed. These facts should be considered before closure of arteriovenous fistulas. In conclusion, the ideal patient for arteriovenous fistula closure should have the minimum risk for graft failure.
Bookmark/Search this post with
Abstract (Original Language): 
Başarılı renal transplantasyon sonrası arteriyovenöz fistüllerin korunması tartışma konusudur. Arteriyovenöz fistüller, sol ventrikül volüm yüklenmesine ve eksantrik sol ventrikül hipertro-fisine yol açmaktadır. Transplant hastalarında da çalışan arteriyovenöz fistül varsa sol ventrikül kitlesi daha fazla olmaktadır. Ancak arteriyovenöz fistüllerin kapatılması ile sol ventrikül geometrisinin tümüyle normale gelmemesi, olası kan basıncı yüksekliği, yeniden diyaliz ihtiyacı halinde yeni AV fistül için damar yolu bulma şansı, her zaman göz önüne alınmalıdır. Sonuç olarak, fistül kapatılması için ideal hasta, graft yetmezliği için en az risk taşıyan hasta olmalıdır.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_16_pp_51-53.pdf
  • 2
51-53
  • Turkish

REFERENCES

References: 

1. Harnett JD, Kenl GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospective followed cohort of dialysis patients. .1 Am Soc Nephrol 1994;4:1486-1490.
2. Rigatto C, Foley R, Jeffery J, Negrijn C, Trilnıla C, Parfrey P. Electrocardiographic left ventricular hypertn >phy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Sen- Nephrol 2003;14:462-468.
3. Meeus F, KourUsky O, Guerin AP, Gaudry C, Marchais SJ, London GM. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int 2000:76:140-147.
4. Parfrey PS, Harnett .11), Foley RN, et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995;60:908-914.
5. McGregor E, Stewart G, Rodger RS, Jardine AG, Early echocardiography changes and survival following renal transplantation. Nephrol Dial Transplant 2000;15:93-98.
6. Linger P, Wis sing KM. de Pauw L, Neuhauer J, van de Home
S2
Türk
Nefroloj
i Diyaliz ve Transplantasyon Dergisi /Official Journal of the Turkish Society of Nephrology
Renal Transplant
Hastalarınd
a Arteriyovenöz Fistüllerin Kapatılması 0
P. Reduction of Mi ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transpla nta(ton 2002;74:75-79.
7. van Duijnhoven EC, Clieriex EC, Tordoir JH, Koman IP, van Mooll JP, Effect of closure of the arteriovenous list ula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant 2001;16:368r372,
H. Iwashima Y, ikxio T, Takami Y L1 al. Effects of the creation arteriovenous lisiula for hemodialysis on cardiac function and natriuretic peptide levels in CKP. Am J Kidney Dis 2002; 40t974-982.
9. DtHiSl JA. Pielrzak E, Dobson A.Glasziou P. How well does It-type natriuretic peptide predict dealli and cardiac events in patients with hear) failure: systemic rewiev. hr Med I 2005; 330*25-633.
It) Orl y, Kor/ets A, Kat/ M. Peak V, /ahavi I. Gaiter ll. Hemodialysis arteriovenous access; a prospective hemodynamic evaluation: Nephrol Dial Transplant l996;ll:tM-97.
II, London GM. Marchais SJ.Guerin AP Arterial stiffness and
function in end stage renal disease. Adv Chronic Kidney Dis 2004,11:202-9.
12 Erank H, Sclimieder RE. Vogi-Ladner G, Scobel HP. Ncunia-yer HI I. Determinants of left ventricular structure after kidney transplantation. Transplant Proc 2000;32:2801-2806.
13. Parfrey PS, Harnett JD, Eoley RN et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995; 60:908-914.
14. Unger P, Vulez-Roa S, Wissing KM. Hoang AD. van de Kor-ne P. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: A long-term follow-up. Am J Transplant 2004;4:2038-2044.
15. Velez-Roa S, Vaibauer |, Wissing M. et al. Acute arterio-ve-nous fistula occlusion decreases sympathetic activity and improves haroreflex control in kidney transplanted patients. Nephrol Dial Transplant 2004;19:1606-1012.
16. Unger P, Wissing KM. Arteriovenous fistula after renal transplantation: utility, futility or threat? Nephrol Dial Tr.inspl.mt 2006:21:2S4-257.
Official

Thank you for copying data from http://www.arastirmax.com